ROR1 and B-cell chronic lymphocytic leukemia: R Mani et al. reported an anti-ROR1 (tyrosine kinase-like orphan receptor 1) immunoliposomal delivery targeting of chronic lymphocytic leukemia and mantle-cell lymphoma B cells but not normal B cells [18,19,20].